Sleep Duration and Treatment Compliance: a Population-based Cross-sectional Study of Hypertensive Patients in Bangladesh
Overview
General Medicine
Authors
Affiliations
Background: Treatment with appropriate medication is a key factor to control hypertension and reduce the associated risk of complications. However, compliance with treatment is often sub-optimal, especially in developing countries. Our aim in this cross-sectional study is to investigate whether there is an association between sleep duration and treatment compliance among skilled professionals who are experiencing hypertension.
Methods: A questionnaire was given to all skilled professionals who are found hypertensive in an organization of Bangladesh. To assess treatment compliance, questions on self-reported compliance test were used. We collected information on self-reported short sleep duration (6 h or less) along with socio-demographic factors and clinical conditions of the subjects.
Results: Sleep duration is associated with compliance with treatment among hypertensive skilled professionals. We found overall associations of sleep duration (odds ratio (OR) 3.77, confidence interval 1.44-10.83) with treatment compliance among hypertensive patients. In addition, body mass index (OR 1.19), marital status (OR 0.16) and duration of having hypertension are found significant factors for non-compliance with treatment.
Conclusion: There is an association between sleep duration and treatment compliance among the hypertensive patients. However, the study is conducted with a small group of skilled professionals from an organization and it is important to include multi-centers to validate the conclusion.
Hossain A, Ahsan G, Hossain M, Hossain M, Sutradhar P, Alam S BMC Public Health. 2025; 25(1):250.
PMID: 39838337 PMC: 11748311. DOI: 10.1186/s12889-025-21409-z.
Suhel S, Akther N, Islam S, Dhor N, Ahmed M, Hossain A BMC Endocr Disord. 2024; 24(1):265.
PMID: 39696101 PMC: 11653888. DOI: 10.1186/s12902-024-01788-x.
Sharma S, Sharma C, Sharma S, Aryal S, Bhandari B PLoS One. 2024; 19(7):e0305941.
PMID: 38959196 PMC: 11221664. DOI: 10.1371/journal.pone.0305941.
Khoiry Q, Alfian S, van Boven J, Abdulah R Front Public Health. 2023; 11:1104510.
PMID: 37521968 PMC: 10374330. DOI: 10.3389/fpubh.2023.1104510.
Ogugu E, Catz S, Bell J, Drake C, Bidwell J, Gangwisch J Integr Blood Press Control. 2022; 15:53-66.
PMID: 35642173 PMC: 9148584. DOI: 10.2147/IBPC.S359444.